Smartest Doc
Comparative Analysis of Sensitivity to Blood in the Urine for Urine-based Point-of-Care Assays (UBC rapid, NMP22 BladderChek and BTA-stat) in Primary Diagnosis of Bladder Carcinoma
Anticancer Research, 05/16/2012
Clinical Article
Ludecke G et al. – For the primary diagnosis of bladder carcinoma, neither the UBC rapid nor the NMP22 BladderChek point of care (POC) test systems are sensitive to the presence of blood in the urine, whereas BTA stat consistently yields false–positive results due to cross–reactivity to macrohaematuria and microhaematuria up to a density of 150 erythrocytes/µl, thus this system should not be employed for this examination.
